902799-70-6

Basic information

• Product Name: C₂₇H₃₆SiO₄
• Synonyms: C₂₇H₃₆SiO₄
• CAS NO: 902799-70-6
• Molecular Weight: 452.666
• Mol File: 902799-70-6.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: C₂₇H₃₆SiO₄(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₇H₃₆SiO₄(902799-70-6)
• EPA Substance Registry System: C₂₇H₃₆SiO₄(902799-70-6)

Safety Data

• Hazardous Substances Data: 902799-70-6(Hazardous Substances Data)

Upstream product

• 50-69-1 D-ribose 
• 532-20-7 D-Ribose 
• 67814-68-0 2,3-O-isopropylidene-D-ribofuranose 
• 681853-93-0 (1R)-(-)-1-[(4R,5S)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-yl]-2-(tert-butyldiphenylsilyloxy)ethan-1-ol 
• 96690-02-7 5-O-(tert-butyldiphenylsilyl)-2,3-O-isopropylidene-D-ribofuranose 
• 1826-67-1 vinyl magnesium bromide 
• 681853-95-2 (-)-1-[(4S,5S)-2,2-dimethyl-5-vinyl-1,3-dioxolan-4-yl]-2-(tert-butyldiphenylsilyloxy)ethan-1-one 

Downstream Products

• 681853-92-9 (1R,4S,5S)-(+)-4,5-isopropylidenedioxy-1-(tert-butyldiphenylsilyloxymethyl)-2-cyclopenten-1-ol 
• 1440510-01-9 C₂₅H₃₂O₄Si 
• 303963-93-1 (3aS,4S,6aR)-6-(((tert-butyldiphenylsilyl)oxy)methyl)-2,2-dimethyl-3a,6a-dihydro-4H-cyclopenta[d][1,3]dioxol-4-ol 
• 1440510-02-0 C₃₀H₃₃ClN₄O₃Si 
• 1440509-95-4 C₂₈H₄₀N₈O₃ 
• 1440510-03-1 C₂₈H₄₂N₈O₃ 
• 952418-12-1 (1R,4R,5S)-9-[3-(tert-butyldiphenylsilyloxymethyl)-4,5-isopropylidenedioxy-2-cyclopenten-1-yl]adenine 
• 915694-38-1 (3aR,3bR,4aS,5S,5aS)-3b-(((tert-butyldiphenylsilyl)oxy)methyl)-2,2-dimethylhexahydrocyclopropa[3,4]cyclopenta[1,2-d][1,3]dioxol-5-ol 
• 303963-92-0 (3aR,6aR)-6-(((tert-butyldiphenylsilyl)oxy)methyl)-2,2-dimethyl-3a,6a-dihydro-4H-cyclopenta[d][1,3]dioxol-4-one 

Relevant articles and documents

POLYMORPHIC COMPOUNDS AND USES THEREOF

The present invention provides compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries.

Compounds and methods for treating neurological and cardiovascular conditions

The present invention relates to compounds and methods of use thereof for treatment of certain disorders and conditions, for example brain injuries such as stroke or traumatic brain injuries.

Synthesis, activity and metabolic stability of non-ribose containing inhibitors of histone methyltransferase DOT1L

Histone methyltransferase DOT1L is a drug target for MLL leukemia. We report an efficient synthesis of a cyclopentane-containing compound that potently and selectively inhibits DOT1L (Ki = 1.1 nM) as well as H3K79 methylation (IC50 ～